Search All News
Anil Rustgi, the new director of the Herbert Irving Comprehensive Cancer Center, talks about new ideas in cancer research, the best patient care, and the importance of physician-scientists.
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
Source:Wall Street Journal/APJanuary 29, 2013
In addition, five clinician-scientists in leukemia joined Columbia's Herbert Irving Comprehensive Cancer Center this month.
- January 28, 2013
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center has welcomed five new clinician-scientists specializing in leukemia.
- December 17, 2012
"Cancer biology is in the midst of a major transition that has led from a primary focus on oncogenes to a focus on systems," say the Columbia editorial authors, Dr. Victor Grann and Maxine Ashby-Thompson.
- December 10, 2012
Women with breast cancer for whom chemotherapy is most critical are most likely to begin treatment.
- November 15, 2012
Link between kidney defects and neurodevelopmental delays in kids
- November 8, 2012
Women who have surgery for ovarian cancer at high-volume hospitals have superior outcomes than similar patients at low-volume hospitals.
- October 19, 2012
Dr. Katherine Crew found that an extract in green tea, Polyphenon E, appears to inhibit tumor cell growth, migration and invasion.